Interstitial Lung Disease: The Consequences of Misdiagnoses

By América Torres Interstitial lung diseases (ILDs) encompass many unrelated conditions with both known and unknown etiologies, which often present diagnostic and therapeutic difficulties for treating physicians. Many believe that early specific diagnosis and immediate management are of no value, as the prognosis and treatment response are universally poor. Due to this belief, many patients […]

EVALI: The critical role of vaping in lung injury cases

By América Torres Photo: Prostooleh/Freepik Vaping as the Cause of EVALI (E-cigarette or Vaping Product Use–Associated Lung Injury), a pulmonary disease that can be severe and potentially life-threatening. The term was coined at the same time the disease was first recognized in August 2019. It is important to clarify that EVALI is not a clinical […]

Advanced Oscillometry Insights: Managing Asthma and COPD

By América Torres Oscillometry is a non-invasive method for measuring the mechanical properties of the respiratory system, which can enhance our understanding and management of lung diseases such as asthma and COPD. This technique offers special advantages in situations where spirometry and other lung function tests are not suitable for patients, such as infants, people […]

2023 American College of Rheumatology  Guideline for the Screening andMonitoring of Interstitial Lung Disease in Patients with Systemic AutoimmuneRheumatic Disease

By América Torres peoplecreations/Freepik With the aim of providing you with information that may be useful in your medical practice, the Guide have summarized the main recommendations of the 2023 American College of Rheumatology Guideline for the Detection and Monitoring of Interstitial Lung Disease (ILD) in individuals with systemic autoimmune disease. Rheumatic disease. This clinical […]

The crucial role of spirometry to enhance lung health

By América Torres Spirometry is fundamental in the assessment of overall pulmonary function. It allows analyzing the impact on lung function caused by various diseases, evaluating the airways’ response to medical treatment, monitoring the disease’s progression, or the outcome of therapeutic interventions, and determining the prognosis for many pulmonary conditions. In this article, we will […]

Updates in the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

By América Torres Photo: brgfx/Freepik The 2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias (VA) and the Prevention of Sudden Cardiac Death (SCD) include recommendations aimed at improving the quality of life of patients. Here is a summary of the new sections and concepts, as well as some of the updates contained […]

Clinical Benefits of Oscillometry in Respiratory Assessment

By América Torres Oscillometry is a non-invasive method to measure the mechanical properties of the respiratory system. This diagnostic tool enhances the valuable contributions of spirometry for the diagnosis, assessment, and monitoring of respiratory diseases such as asthma and COPD.   In this article, we will discuss the clinical advantages of oscillometry as a complementary […]

Asthma: Exploring its Impactful Figures

By América Torres According to the GINA Guide 2019, asthma is estimated to affect 300 million people worldwide. In fact, it is one of the most common and costly diseases in the United States. It consists of diffuse inflammation of the airways caused by various stimuli, which cause a partial or completely reversible bronchoconstriction. Symptoms […]

Emphysema: ESI, a new marker of severity

By América Torres Emphysema detected by CT scan has a new marker of severity. It is the ESI index (Emphysema Severity Index) a novel marker (based on spirometry) that still has no clear clinical validity. Despite this, it provides information that has made it possible to establish a relationship between this index and death from […]

Relationship between decline in lung function and cardiovascular risk

By América Torres Photo Lifestyle memory / Freepik The decline in lung function begins around the age of 25: an annual FEV1 drop between 25 and 30 ml is considered normal. Among influencing factors we can include smoking, environmental and behavioral factors and genetics. While this is a well-known predictor of COPD and is associated […]